Delivery Order SPE2DB22D1017-SPE2DB24FG3ER

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,236.32, is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a prescription medication. This is a firm fixed price delivery order contract with a completion date of September 6, 2024. The contract does not have a set-aside designation. As a large pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. The contract has a ceiling value of $2,699.20 and is a Firm Fixed Price Delivery Order, with a completion date of December 12, 2024. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not designated with any set-aside requirements, indicating open competition. The contract is...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,520.70 firm fixed-price delivery order is for HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has an ultimate completion date of June 23, 2025 and is not set aside. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, to provide Humulin R 500 unit/mL KwikPen 3mL to the Defense Logistics Agency (DLA). The firm fixed price delivery order has a potential value of $2,236.93 and a period of performance through February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This order is being issued under Amerisourcebergen...
This federal contract award, with ID SPE2DB22D1017|SPE2DB24FG6AJ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $19,841.63 firm fixed-price delivery order is for the supply of Humulin R 500 unit/mL Kwikpen, a medication used to manage diabetes. The contract has a performance period through September 30, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts to provide a...
This federal contract award is for the delivery of Humulin R 500 unit/ml KwikPen 3ml to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The fixed-price delivery order has a ceiling value of $9,328.16 and a completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,485.76 firm-fixed-price delivery order is for the supply of Humulin R 500 Unit/mL KwikPen 3mL, a type of insulin medication. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this as part of its Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,646.28 firm fixed-price delivery order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. The contract has a ceiling value of $4,646.28 and a period of performance through February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specific pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,067.69 and is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL. The $10,628.96 firm-fixed price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3ER
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humulin R 500 Unit/ML KwikPen 3 ML. The contract has a ceiling value of $11,434.47 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 15, 2024. The contract is not set aside for any specific business type. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, to provide a comprehensive range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies, to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives nationwide.

Generated 11/13/24, 9:15 AM